Shares of agilon health, inc. (NYSE:AGL – Get Free Report) have received an average rating of “Hold” from the nineteen brokerages that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and four have assigned a buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $9.10.
A number of brokerages recently issued reports on AGL. Robert W. Baird began coverage on shares of agilon health in a research note on Thursday, May 30th. They issued a “neutral” rating and a $6.00 price target on the stock. Baird R W upgraded shares of agilon health to a “hold” rating in a research note on Thursday, May 30th. Citigroup started coverage on shares of agilon health in a research note on Monday, April 22nd. They set a “neutral” rating and a $6.00 target price on the stock. Stifel Nicolaus lowered their target price on shares of agilon health from $8.00 to $7.00 and set a “hold” rating on the stock in a research note on Wednesday, May 1st. Finally, Truist Financial upped their target price on shares of agilon health from $6.40 to $6.50 and gave the company a “hold” rating in a research note on Friday, May 24th.
View Our Latest Research Report on agilon health
Institutional Investors Weigh In On agilon health
agilon health Stock Performance
Shares of agilon health stock opened at $5.75 on Wednesday. The stock has a market cap of $2.36 billion, a price-to-earnings ratio of -8.21 and a beta of 0.60. The firm’s 50-day moving average is $6.01 and its 200 day moving average is $6.44. agilon health has a 1 year low of $4.41 and a 1 year high of $21.52. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.33 and a quick ratio of 1.33.
agilon health (NYSE:AGL – Get Free Report) last announced its quarterly earnings results on Tuesday, May 7th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.03. The company had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.62 billion. agilon health had a negative net margin of 5.67% and a negative return on equity of 26.15%. Sell-side analysts anticipate that agilon health will post -0.34 EPS for the current fiscal year.
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
See Also
- Five stocks we like better than agilon health
- What is the S&P/TSX Index?
- 3 Insider-Buy Stocks to Add to Your Watchlist Now
- 3 REITs to Buy and Hold for the Long Term
- Commvault Stock: AI Cybersecurity Giant Ready to Double Again
- 3 Warren Buffett Stocks to Buy Now
- Intuit Stock Ready to Soar: RBC Sees Big Upside with GenAI
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.